Rocket One Inc. Federal Income Tax Expense (Benefit), Continuing Operations
Rocket One Inc. (RKTO) reported Federal Income Tax Expense (Benefit), Continuing Operations of $57.20 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-27.
Financial Statements › Expense Statement › Income Tax
us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations · last filed 2026-03-27
- Rocket One Inc. federal income tax expense (benefit), continuing operations for fiscal 2025 was $57.20M.
| Period end | Federal Income Tax Expense (Benefit), Continuing Operations | Federal Income Tax Expense (Benefit), Continuing Operations as first filed | Federal Income Tax Expense (Benefit), Continuing Operations 12 month |
|---|---|---|---|
| 2025-12-31 | $57.20M 10-K · filed 2026-03-27 | ||
| 2017-12-31 | $40.50M 10-K · filed 2025-03-28 | $36.00M 10-K · filed 2024-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |